Showing 1011-1020 of 1350 results for "".
- Topical Collagen Powder May Be Effective for Wound Closurehttps://practicaldermatology.com/news/collagen-may-be-effective-for-wound-closure/2460091/Collagen powder is as effective in managing skin biopsy wounds as primary closure with non-absorbable sutures, according to a first-of-its-kind study published in the Journal of Drugs in Dermatology. Researchers investigated the efficacy of topical collagen powder compared
- Proactiv Works to Change the Conversation about Acne with New Initiativeshttps://practicaldermatology.com/news/proactiv-works-to-change-the-conversation-about-acne-with-new-initiatives/2460072/Proactiv is taking on the acne positivity movement with new initiatives aimed to help validate the emotional journey of people with acne and inspire compassion for others. As part of these initiatives, Brand Ambassador Kendall Jenner will continue
- Sonrei Sea Clearly Gel Sunscreens Launchhttps://practicaldermatology.com/news/sonrei-sea-clearly-gel-sunscreens-launch/2460070/A new eco-friendly, gel-based sunscreen line from Sonrei, LLC is now available. “Crafted for every kind,” Sonrei is driven by a commitment of bringing to market a translucent broad-spectrum SPF with environmental principles at the core, the company says. Sonrei Sea Clearly T
- Novartis: New Data Show Cosentyx Has Durable Response Across Psoriatic Diseasehttps://practicaldermatology.com/news/novartis-new-data-show-cosentyx-has-durable-response-across-psoriatic-disease/2460068/A new comprehensive analysis shows the long-term efficacy and safety of secukinumab in multiple manifestations of psoriatic disease, including moderate-to-severe plaque-type, nail and palmoplantar psoriasis, psoriatic arthritis and ankylosing spondylitis. Data are derived from key Phase 3, random
- Aclaris Therapeutics: Positive 6-Month Results from Phase 2 Open-Label Trial of Topical ATI-502 in Androgenetic Alopeciahttps://practicaldermatology.com/news/aclaris-therapeutics-positive-6-month-results-from-phase-2-open-label-trial-of-topical-ati-502-in-androgenetic-alopecia/2460067/Results from a Phase 2 open-label clinical trial of ATI-502 (AGA-201), an investigational topical Janus Kinase (JAK) 1/3 inhibitor are promising for patients with androgenetic alopecia (AGA). Aclaris Therapeutics announced the findings and says 12-month data should be available by year’s en
- Gillette Skin Guard Reduces Razor Bumps by 60%https://practicaldermatology.com/news/gillette-skin-guard-reduces-razor-bumps-by-60/2460065/Gillette’s recently launched SkinGuard razor is helping men who are susceptible to razor bumps, also known as Pseudofolliculitis barbae or PFB, new research shows. Results from a recent clinical study from Wake Forest University revealed that the incidence of men’
- Blue Lizard Australian Sunscreen Partners with Sesame Workshop, Boston Red Soxhttps://practicaldermatology.com/news/blue-lizard-australian-sunscreen-partners-with-sesame-workshop-boston-red-sox/2460034/Crown Laboratories, Inc’s. Blue Lizard Australian Sunscreen is partnering with Sesame Workshop with a new line of sunscreen for babies and kids. The Sesame Street and Blue Lizard line features Elmo on the mineral-based baby sunscreen
- Obagi Launches SKINCLUSION Initiative to Celebrate Diversity with Brand Ambassador Priyanka Chopra Jonashttps://practicaldermatology.com/news/obagi-launches-skinclusion-initiative-to-celebrate-diversity-with-brand-ambassador-and-priyanka-chopra-jonas/2460026/Obagi kicked off its SKINCLUSION initiative, designed to elevate the global dialogue about diversity and how we can all make conscious choices to see the beauty in all of our differences, with an event in New York City introducing Priyanka Chopra Jonas as its SKINCLUSION ambassador. Priyanka, an
- Industry Vet Linda Esposito Named New CFO at Skyn ICELANDhttps://practicaldermatology.com/news/industry-vet-linda-esposito-named-new-cfo-at-skyn-iceland/2460002/Linda Esposito is the new Chief Financial Officer at Skyn ICELAND, a privately held New York-based skin care company. Ms. Esposito will report to Founder and Chief Executive Officer Sarah Kugelman and will oversee all financial aspects of t
- Allergan 360° Aesthetics Report Shines Light on Evolving Beauty Perceptions Around the Worldhttps://practicaldermatology.com/news/allergan-3600-aesthetics-report-shines-light-on-evolving-beauty-perceptions-around-the-world/2459994/The digital boom and millennials are growing the aesthetics category, and wellness and self-care are the new key drivers, according to the Allergan 360° Aesthetics Report. To develop the report, Allergan tapped into more than 14,500